Dr. Ankur Mudgal

Associate Consultant - Medical Onco & Haemato Oncology Cancer Institute

Gurugram

About

Dr Ankur Mudgal is Associate consultant in Department of Medical Oncology and Haematology at Medanta hospital, Gurugram. He has gained widespread experience in diagnosing and treating all solid and hematological malignancies with special interest in Breast , Lung , Gastrointestinal and Genitourinary cancers. He has overall experience of more than 8 years in the field of oncology. He has done preceptorship in Immuno-oncology from Singapore conducted by European Society of Medical Oncology. He has expertise in administering all types of chemotherapy , targeted therapy , immunotherapy and hormonal therapy. He also has keen interest in personalized treatment of all malignancies, precision oncology , preventive oncology , geriatric oncology and palliative care. 

Medical Qualifications

QUALIFICATIONS INSTITUTE / DEPARTMENT YEAR
DNB ( Medical Oncology )Medanta The Medicity, Gurugram2022
MD ( Radiation Oncology )Sarojini Naidu Medical College, Agra2018
MBBSNetaji Subhash Chandra Bose Subharti Medical College, Meerut2012

Specialization and Expertise

  • Breast cancer
  • Thoracic cancers
  • Gastrointestinal cancers
  • Genitourinary cancers

Memberships & Certifications

  • European Society for Medical Oncology
  • Indian society of Medical and Pediatric oncology
  • American Society of Clinical oncology
  • Association of Radiation oncologist of India

Publications

  • :   Mudgal .A , Arya A , Yadav I , Chaudhary S . 2018 Role of hypofractionated palliative radiotherapy in patients with stage four head and neck squamous cell carcinoma accepted in journal of cancer research and therapeutics,
  • :   Gupta S , Mudgal A , Singh P, Agarawal P . Recurrent desmoplastic ameloblastoma of maxilla published in International journal of current medical and pharmaceutical research (Vol 4 . Issue 7A , 3434-3436 , july 2018),
  • :   Mudgal A , Arya A , Yadav I , Pandey L . Retrospective evaluation comparing palliative chemotherapy in management of recurrent head and neck cancer . (Poster) AROICON 2016 Journal of cancer research and therapeutics Vol12, supplement 1­2015 pg S46,
  • :   Gupta S , Mudgal A , Pandey L, Agarawal P Vaginal And Bone Metastasis with Retroperitoneal Lymphadenopathy From Renal Cell Carcinoma: A Very Unusual Presentation Indian Journal of Cancer Education and Research Volume 6 Number 2, July - December 2018,
  • :   Mudgal A, Vaid AK, Sahoo MK, Wadhwa J, Sood N, Gautam D. 215P Prospective observational study to evaluate impact of metabolic tumor volume on baseline 18F FDG PET/CT and molecular markers on tumor response rate in patients with diffuse large B-cell lymphoma. Annals of Oncology. 2022 Nov 1;33:S1518.,
Feedback